Zobrazeno 1 - 10
of 87
pro vyhledávání: '"Byambaa Enkhmaa"'
Autor:
Hayley G. Law, Kimber L. Stanhope, Wei Zhang, Munkhtuya Myagmarsuren, Zahraa M. Jamshed, Muhammad A. Khan, Heejung Bang, Peter J. Havel, Lars Berglund, Byambaa Enkhmaa
Publikováno v:
Journal of Lipid Research, Vol 65, Iss 8, Pp 100588- (2024)
Lipoprotein(a) [Lp(a)] contributes to cardiovascular disease risk. A genetically determined size polymorphism in apolipoprotein(a) [apo(a)], determined by the number of Kringle (K) repeats, inversely regulates Lp(a) levels. Nongenetic factors includi
Externí odkaz:
https://doaj.org/article/021bbcde04bc4ad6a758b3b7676f954e
Autor:
Hayley G. Law, Muhammad A. Khan, Wei Zhang, Heejung Bang, Jennifer Rood, Marlene Most, Michael Lefevre, Lars Berglund, Byambaa Enkhmaa
Publikováno v:
Journal of Lipid Research, Vol 64, Iss 9, Pp 100420- (2023)
Reducing dietary saturated fatty acids (SFA) intake results in a clinically significant lowering of low-density lipoprotein cholesterol (LDL-C) across ethnicities. In contrast, dietary SFA’s role in modulating emerging cardiovascular risk factors i
Externí odkaz:
https://doaj.org/article/c12c068748c646fcb58d1a34e277abaa
Autor:
Lars Berglund, Kyoungmi Kim, Wei Zhang, Nishant Prakash, Kevin Truax, Erdembileg Anuurad, Byambaa Enkhmaa
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 10, Iss 17 (2021)
Background Lp(a) (lipoprotein(a)) is the major lipoprotein carrier of oxidized phospholipids (OxPL) and this function mediates Lp(a) atherogenicity. However, the relationship between OxPL, Lp(a), and genetic and biological characteristics remains poo
Externí odkaz:
https://doaj.org/article/bff81f551d79461fbe24d0d5f44b6747
Publikováno v:
Journal of Lipid Research, Vol 60, Iss 9, Pp 1603-1609 (2019)
Heritability of LPA allele, apo(a) isoform sizes, and isoform-associated lipoprotein(a) [Lp(a)] levels was studied in 82 Caucasian and African-American families with two parents and two children (age: 6–74 years). We determined: 1) Lp(a) levels; 2)
Externí odkaz:
https://doaj.org/article/bb194aca06cc45da896f93f62495f573
Autor:
Byambaa Enkhmaa, Erdembileg Anuurad, Wei Zhang, Chin-Shang Li, Robert Kaplan, Jason Lazar, Dan Merenstein, Roksana Karim, Brad Aouizerat, Mardge Cohen, Kenneth Butler, Savita Pahwa, Igho Ofotokun, Adaora A. Adimora, Elizabeth Golub, Lars Berglund
Publikováno v:
Journal of Lipid Research, Vol 59, Iss 10, Pp 1967-1976 (2018)
We previously demonstrated an association between lipoprotein (a) [Lp(a)] levels and atherosclerosis in human immunodeficiency virus (HIV)-seropositive women. The effects of antiretroviral therapy (ART) on Lp(a) levels in relation to apo(a) size poly
Externí odkaz:
https://doaj.org/article/dbabce8580c548f08df9afa0243eb592
Autor:
Brooke E. Wickman, Byambaa Enkhmaa, Ronit Ridberg, Erick Romero, Martin Cadeiras, Frederick Meyers, Francene Steinberg
Publikováno v:
Nutrients, Vol 13, Iss 12, p 4424 (2021)
Heart failure (HF) is a major health care burden increasing in prevalence over time. Effective, evidence-based interventions for HF prevention and management are needed to improve patient longevity, symptom control, and quality of life. Dietary Appro
Externí odkaz:
https://doaj.org/article/3f7d192c04e7466cba24a571d4dfd472
Publikováno v:
Journal of Lipid Research, Vol 58, Iss 10, Pp 2008-2016 (2017)
An elevated level of lipoprotein (a) [Lp(a)] is a risk factor for CVD. Alirocumab, a monoclonal antibody to proprotein convertase subtilisin/kexin type 9, is reported to reduce Lp(a) levels. The relationship of Lp(a) reduction with apo(a) size polymo
Externí odkaz:
https://doaj.org/article/754d99a071644969a2dcfe67624f3f09
Publikováno v:
Journal of Lipid Research, Vol 57, Iss 7, Pp 1111-1125 (2016)
Levels of lipoprotein (a) [Lp(a)], a complex between an LDL-like lipid moiety containing one copy of apoB, and apo(a), a plasminogen-derived carbohydrate-rich hydrophilic protein, are primarily genetically regulated. Although stable intra-individuall
Externí odkaz:
https://doaj.org/article/4226bce7016e4913ba0c4a7a32006733
Publikováno v:
Nutrients, Vol 12, Iss 7, p 2024 (2020)
Lipoprotein(a) [Lp(a)] is an independent, causal, genetically determined risk factor for cardiovascular disease (CVD). We provide an overview of current knowledge on Lp(a) and CVD risk, and the effect of pharmacological agents on Lp(a). Since evidenc
Externí odkaz:
https://doaj.org/article/b2685445aa8445ff9b15f1c6091d17d7
Autor:
Anuurad Erdembileg, Annie Mirsoian, Byambaa Enkhmaa, Wei Zhang, Laurel A Beckett, William J Murphy, Lars F Berglund
Publikováno v:
PLoS ONE, Vol 10, Iss 3, p e0121947 (2015)
The overall burden of chronic disease, inflammation and cardiovascular risk increases with age. Whether the relationship between age and inflammation is impacted by presence of an adverse metabolic burden is not known.We determined inflammatory marke
Externí odkaz:
https://doaj.org/article/1c827a5d3a734578a7487924cbb45aaa